Scanner Tech Corphttps://investorshangout.com/Scanner-Tech-Corp-SCNI-66486/en-usThu, 29 Oct 2026 00:56:53 GMTCopyright InvestorsHangout.comNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports First-Half 2026 Resultshttps://investorshangout.com/post/view?id=6841904https://investorshangout.com/post/view?id=6841904Mon, 24 Aug 2026 20:59:33 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports First-Half 2025 Resultshttps://investorshangout.com/post/view?id=6786157https://investorshangout.com/post/view?id=6786157Tue, 02 Sep 2025 20:03:56 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Publishes Peer-Reviewed Data Suhttps://investorshangout.com/post/view?id=6779459https://investorshangout.com/post/view?id=6779459Tue, 29 Jul 2025 20:05:15 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Highlights PC111 Breakthrough Ahttps://investorshangout.com/post/view?id=6772669https://investorshangout.com/post/view?id=6772669Thu, 26 Jun 2025 19:53:03 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Highlights Growth and SEPA Fundhttps://investorshangout.com/post/view?id=6770313https://investorshangout.com/post/view?id=6770313Thu, 12 Jun 2025 20:38:53 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q1 Revenue Growth Drivehttps://investorshangout.com/post/view?id=6767207https://investorshangout.com/post/view?id=6767207Fri, 30 May 2025 19:43:43 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports $4.8 Million Net Gain ihttps://investorshangout.com/post/view?id=6759416https://investorshangout.com/post/view?id=6759416Thu, 08 May 2025 19:55:07 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Host Webinar on PC111 Antibohttps://investorshangout.com/post/view?id=6757952https://investorshangout.com/post/view?id=6757952Thu, 01 May 2025 20:53:02 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Option Agreement to Acquhttps://investorshangout.com/post/view?id=6752547https://investorshangout.com/post/view?id=6752547Thu, 27 Mar 2025 20:13:08 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Present at BIO-Europe Springhttps://investorshangout.com/post/view?id=6750685https://investorshangout.com/post/view?id=6750685Mon, 17 Mar 2025 19:28:47 GMTNetworkNewsWire: Layoffs, Upheaval at CDC Trigger Fears on Handling Disease Outbreaks America is facing thrhttps://investorshangout.com/post/view?id=6747955https://investorshangout.com/post/view?id=6747955Fri, 28 Feb 2025 21:43:10 GMTNetworkNewsWire: Biomaterial Modification Could Yield Better Cancer Therapies, Study Finds Altering the phyhttps://investorshangout.com/post/view?id=6744338https://investorshangout.com/post/view?id=6744338Tue, 11 Feb 2025 21:51:50 GMTNetworkNewsWire: New Trump Admin Could Drastically Change Research on Infectious Diseases For decades now, https://investorshangout.com/post/view?id=6741049https://investorshangout.com/post/view?id=6741049Thu, 23 Jan 2025 21:42:04 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Engage Investors and Partnerhttps://investorshangout.com/post/view?id=6738547https://investorshangout.com/post/view?id=6738547Mon, 06 Jan 2025 20:42:02 GMTNetworkNewsWire: Researchers Identify Protein That Makes Cancer Evade Cell Therapy CAR T cell therapy is dehttps://investorshangout.com/post/view?id=6737300https://investorshangout.com/post/view?id=6737300Fri, 27 Dec 2024 21:44:46 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Expands CDMO Operations with Nehttps://investorshangout.com/post/view?id=6735669https://investorshangout.com/post/view?id=6735669Mon, 16 Dec 2024 21:01:31 GMTNetworkNewsWire: Cases of Parvovirus B19 Spike in the US Parvovirus B19, often referred to as the B19 virushttps://investorshangout.com/post/view?id=6734033https://investorshangout.com/post/view?id=6734033Fri, 06 Dec 2024 22:09:03 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Strategic Board Appoihttps://investorshangout.com/post/view?id=6733677https://investorshangout.com/post/view?id=6733677Thu, 05 Dec 2024 20:05:16 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Welcomes Dr. Jonathan Sadeh to https://investorshangout.com/post/view?id=6732288https://investorshangout.com/post/view?id=6732288Wed, 27 Nov 2024 20:41:28 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Nine-Month Financial Rehttps://investorshangout.com/post/view?id=6731348https://investorshangout.com/post/view?id=6731348Fri, 22 Nov 2024 20:10:20 GMTNetworkNewsWire: New Drug Approach Could Roll Back Pancreatic Cancer Immunotherapy Resistance New research https://investorshangout.com/post/view?id=6730616https://investorshangout.com/post/view?id=6730616Tue, 19 Nov 2024 21:46:41 GMTNetworkNewsWire: New Toolkit Launched to Boost Marburg Screening Readiness in the US Thus far, Rwanda has chttps://investorshangout.com/post/view?id=6726829https://investorshangout.com/post/view?id=6726829Thu, 31 Oct 2024 21:44:11 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Spotlight Innovative I&I Piphttps://investorshangout.com/post/view?id=6726825https://investorshangout.com/post/view?id=6726825Thu, 31 Oct 2024 21:08:43 GMTNetworkNewsWire: Researchers Shine Spotlight on New Barriers to Vaccination The 20th century saw many advanhttps://investorshangout.com/post/view?id=6723660https://investorshangout.com/post/view?id=6723660Mon, 14 Oct 2024 21:02:47 GMTNetworkNewsWire: Whooping Cough Prevalence Rises in US as Missed Shots During Pandemic Come Home to Roost Nhttps://investorshangout.com/post/view?id=6720367https://investorshangout.com/post/view?id=6720367Wed, 25 Sep 2024 21:32:21 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Schedules Virtual Panel Discusshttps://investorshangout.com/post/view?id=6718708https://investorshangout.com/post/view?id=6718708Mon, 16 Sep 2024 20:59:42 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) CEO Featured Guest on Latest Ephttps://investorshangout.com/post/view?id=6717457https://investorshangout.com/post/view?id=6717457Mon, 09 Sep 2024 21:50:49 GMTNetworkNewsWire: New Approach Could Boost Effectiveness of Immunotherapies Against Colorectal Cancer Colorehttps://investorshangout.com/post/view?id=6716644https://investorshangout.com/post/view?id=6716644Wed, 04 Sep 2024 21:14:30 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), EIB Close on Loan Restructurinhttps://investorshangout.com/post/view?id=6714640https://investorshangout.com/post/view?id=6714640Wed, 21 Aug 2024 20:07:21 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Into $2M Investment Commhttps://investorshangout.com/post/view?id=6714426https://investorshangout.com/post/view?id=6714426Tue, 20 Aug 2024 20:17:01 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q2 2024 Financial Resulhttps://investorshangout.com/post/view?id=6713176https://investorshangout.com/post/view?id=6713176Thu, 15 Aug 2024 20:11:38 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Signs Definitive Loan Restructuhttps://investorshangout.com/post/view?id=6712192https://investorshangout.com/post/view?id=6712192Tue, 13 Aug 2024 19:53:28 GMTNetworkNewsWire: Study Highlights Heightened Risk of Diseases Spreading from Animals to Humans New researchhttps://investorshangout.com/post/view?id=6708946https://investorshangout.com/post/view?id=6708946Fri, 26 Jul 2024 20:59:11 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives PEI Feedback Regardinghttps://investorshangout.com/post/view?id=6708278https://investorshangout.com/post/view?id=6708278Tue, 23 Jul 2024 20:16:30 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Successful Preclinicalhttps://investorshangout.com/post/view?id=6706783https://investorshangout.com/post/view?id=6706783Mon, 15 Jul 2024 20:22:56 GMTNetworkNewsWire: Study Explores Starving Malignant Cells to Boost Immunotherapy, Improve DNA Damage Prostathttps://investorshangout.com/post/view?id=6706418https://investorshangout.com/post/view?id=6706418Fri, 12 Jul 2024 20:47:20 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives Updated LoI from the Ehttps://investorshangout.com/post/view?id=6705381https://investorshangout.com/post/view?id=6705381Mon, 08 Jul 2024 20:32:08 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Q1 2024 Financial Repohttps://investorshangout.com/post/view?id=6704520https://investorshangout.com/post/view?id=6704520Tue, 02 Jul 2024 21:18:38 GMTNetworkNewsWire: Study Finds Infectious Diseases Have Surged Post COVID-19 Pandemic New research has determhttps://investorshangout.com/post/view?id=6703261https://investorshangout.com/post/view?id=6703261Wed, 26 Jun 2024 21:09:24 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives LOI with European Invehttps://investorshangout.com/post/view?id=6700721https://investorshangout.com/post/view?id=6700721Thu, 13 Jun 2024 20:46:41 GMTNetworkNewsWire: NIH Researchers Unveil AI Tool to Predict Oncology Patients’ Response to Immunotherapy Scihttps://investorshangout.com/post/view?id=6699430https://investorshangout.com/post/view?id=6699430Fri, 07 Jun 2024 21:19:48 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Regains Compliance with Nasdaq https://investorshangout.com/post/view?id=6699420https://investorshangout.com/post/view?id=6699420Fri, 07 Jun 2024 21:03:14 GMTNetworkNewsWire: Study Offers Insights on Why Autoimmune Conditions Disproportionately Afflict Women Autoimhttps://investorshangout.com/post/view?id=6695175https://investorshangout.com/post/view?id=6695175Mon, 20 May 2024 21:14:25 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases FY 2023 Financial Resuhttps://investorshangout.com/post/view?id=6694258https://investorshangout.com/post/view?id=6694258Thu, 16 May 2024 20:44:48 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Nasdaq Delisting Notihttps://investorshangout.com/post/view?id=6691343https://investorshangout.com/post/view?id=6691343Mon, 06 May 2024 21:02:21 GMTNetworkNewsWire: Vitamin D Could Balance Gut Microbiota, Boost Cancer Immunotherapy Vitamin D plays differehttps://investorshangout.com/post/view?id=6690009https://investorshangout.com/post/view?id=6690009Wed, 01 May 2024 21:04:09 GMTNetworkNewsWire: Study Finds Presurgery Immunotherapy Safe for Patients with Pancreatic Cancer Pancreatic chttps://investorshangout.com/post/view?id=6684328https://investorshangout.com/post/view?id=6684328Fri, 12 Apr 2024 20:57:42 GMTNetworkNewsWire: NetworkNewsBreaks – InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Chief Sciehttps://investorshangout.com/post/view?id=6683524https://investorshangout.com/post/view?id=6683524Wed, 10 Apr 2024 21:18:21 GMTNetworkNewsWire: NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), Scinai Bioservices Enter MSA whttps://investorshangout.com/post/view?id=6683078https://investorshangout.com/post/view?id=6683078Mon, 08 Apr 2024 20:26:52 GMTNetworkNewsWire: Gene Signature Could Predict NSC Lung Cancer Response to Immunotherapy New research has fohttps://investorshangout.com/post/view?id=6679698https://investorshangout.com/post/view?id=6679698Fri, 22 Mar 2024 22:49:24 GMT